In accord with these findings, our group has already reported that the levels of tracheal aspirate YKL-40 (the human homolog of BRP-39) were lower in premature infants treated with hyperoxia for respiratory failure who subsequently developed BPD or died compared with those that did not experience these complications [8]. The gene discussed is CHI3L1; the disease is respiratory failure.